These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1280430)

  • 1. Detection of antibody to hepatitis C E2/NS1 protein in patients with type C hepatitis.
    Yokosuka O; Ito Y; Imazeki F; Ohto M; Omata M
    Biochem Biophys Res Commun; 1992 Nov; 189(1):565-71. PubMed ID: 1280430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High detection rate of hepatitis C virus E2 antibody in patients with type C hepatitis.
    Yokosuka O; Ito Y; Ohto M; Omata M
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():52-4. PubMed ID: 7689507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
    Sakashita H
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of HCV E2/NS1 protein as a fusion protein with maltose binding protein: detection of anti-E2/NS1 antibody in chronic liver disease.
    Yokosuka O; Omata M; Ito Y; Ohto M
    Gut; 1993; 34(2 Suppl):S64-5. PubMed ID: 7686121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the amino-terminal half of the NS1 region of the hepatitis C virus genome and detection of an antibody to the expressed protein in patients with liver diseases.
    Inoue Y; Suzuki R; Matsuura Y; Harada S; Chiba J; Watanabe Y; Saito I; Miyamura T
    J Gen Virol; 1992 Aug; 73 ( Pt 8)():2151-4. PubMed ID: 1379627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection.
    Tsai SL; Chen PJ; Hwang LH; Kao JH; Huang JH; Chang TH; Chen DS
    J Hepatol; 1994 Sep; 21(3):403-11. PubMed ID: 7530738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus replication and antibodies to structural and nonstructural viral proteins in chronic hepatitis C.
    Yuki N; Hayashi N; Hagiwara H; Naito M; Kasahara A; Fusamoto H; Kamada T
    J Hepatol; 1994 Mar; 20(3):421-5. PubMed ID: 7516952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection.
    Yuki N; Hayashi N; Kasahara A; Hagiwara H; Mita E; Ohkawa K; Katayama K; Fusamoto H; Kamada T
    Hepatology; 1996 May; 23(5):947-52. PubMed ID: 8621173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of specific antibody assay for genotyping of hepatitis C virus.
    Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
    Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of hepatitis C virus core protein as a fusion protein with maltose binding protein. Detection of anti-hepatitis C core antibody by western blot.
    Yokosuka O; Ito Y; Sakuma J; Imazeki F; Ohto M; Omata M
    Dig Dis Sci; 1993 Apr; 38(4):626-30. PubMed ID: 7681745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and antibody profiles of chronic hepatitis C patients: relation to hepatitis C virus genotypes.
    Yuki N; Hayashi N; Mita E; Hagiwara H; Oshita M; Ohkawa K; Katayama K; Kasahara A; Fusamoto H; Kamada T
    J Med Virol; 1995 Feb; 45(2):162-7. PubMed ID: 7539828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.
    Lok AS; Chien D; Choo QL; Chan TM; Chiu EK; Cheng IK; Houghton M; Kuo G
    Hepatology; 1993 Sep; 18(3):497-502. PubMed ID: 7689528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b.
    Saracco G; Rosina F; Abate ML; Chiandussi L; Gallo V; Cerutti E; Di Napoli A; Solinas A; Deplano A; Tocco A
    Hepatology; 1993 Dec; 18(6):1300-5. PubMed ID: 7694894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors.
    McGuinness PH; Bishop GA; Lien A; Wiley B; Parsons C; McCaughan GW
    Hepatology; 1993 Sep; 18(3):485-90. PubMed ID: 7689526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C.
    Kobayashi M; Tanaka E; Matsumoto A; Ichijo T; Kiyosawa K
    J Gastroenterol Hepatol; 1997 Jan; 12(1):73-6. PubMed ID: 9076628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C.
    Quiroga JA; Herrero M; Castillo I; Navas S; Pardo M; Carreño V
    J Infect Dis; 1994 Sep; 170(3):669-73. PubMed ID: 7521377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
    Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
    J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus RNA and anti-N14 antibody levels during interferon alpha therapy for chronic hepatitis C.
    Oketani M; Tanaka K; Sho Y; Maeda E; Miyazaki H; Arima T
    Intern Med; 1994 Oct; 33(10):588-92. PubMed ID: 7530068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.